Related Experiment Videos
[Helicobacter pylori and nonsteroidal antirheumatics]
O Scherak1, A M Hirschl, H Nemec
1Ludwig-Boltzmann-Institut für Rheumatologie und Fokalgeschehen, Baden.
Deutsche Medizinische Wochenschrift (1946)
|August 3, 1990
Summary
Nonsteroidal anti-rheumatic drugs do not influence Helicobacter pylori colonization in the antral mucosa. This study found similar H. pylori prevalence in patients taking NSAIDs and controls, regardless of gastritis type.
Area of Science:
- Gastroenterology
- Microbiology
- Pharmacology
Background:
- Nonsteroidal anti-rheumatic drugs (NSAIDs) are widely used, and their potential impact on gastric mucosal infections is of clinical interest.
- Helicobacter pylori is a common pathogen associated with gastritis and peptic ulcers.
Purpose of the Study:
- To investigate the prospective occurrence of Helicobacter pylori in the antral mucosa of patients treated with NSAIDs compared to a control group.
- To determine if NSAID use affects H. pylori colonization rates.
Main Methods:
- Prospective study comparing 66 patients on NSAIDs with 33 controls.
- Gastroscopy with antral mucosal biopsies for H. pylori culture.
- Correlation analysis between NSAID use, H. pylori presence, and gastritis severity.
Main Results:
- H. pylori was detected in 54.5% of NSAID users and 66.7% of controls.
- Prevalence varied by gastritis type, with higher rates in chronic active gastritis in both groups.
- No significant difference in H. pylori colonization between NSAID users and controls.
Conclusions:
- NSAID use does not appear to influence the colonization of the antral mucosa by Helicobacter pylori.
- A significant correlation exists between H. pylori detection and the severity of gastric inflammation.